IRVINE, Calif., Aug. 28, 2019 /PRNewswire/ -- Edwards
Lifesciences Corporation (NYSE: EW), the global leader in
patient-focused innovations for structural heart disease and
critical care monitoring, is scheduled to present at the 2019 Wells
Fargo Healthcare Conference at the Westin Copley Place in
Boston, Mass., on Wednesday, Sept. 4, 2019.
Michael A. Mussallem, chairman
and chief executive officer, and Scott B.
Ullem, chief financial officer, are scheduled to speak to
conference attendees at 9:05 a.m.
ET. A live webcast of the presentation will be
available to all interested parties on the Edwards Lifesciences
investor relations website at http://ir.edwards.com/events.cfm.
An archived version of the webcast will be available later
that day on the Edwards investor relations website in the News and
Events section and via the Edwards Lifesciences Investor Relations
App for mobile devices.
About Edwards Lifesciences
Edwards Lifesciences, based
in Irvine, Calif., is the global
leader in patient-focused medical innovations for structural heart
disease and critical care monitoring. Driven by a passion to
help patients, the company collaborates with the world's leading
clinicians and researchers to address unmet healthcare needs,
working to improve patient outcomes and enhance lives. For more
information, visit www.Edwards.com and follow us on Twitter at
@EdwardsLifesci.
Edwards, Edwards Lifesciences, and the stylized E logo are
trademarks of Edwards Lifesciences Corporation.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/edwards-lifesciences-to-present-at-the-2019-wells-fargo-healthcare-conference-300906985.html
SOURCE Edwards Lifesciences Corporation